Discussion  by unknown
Acquired Cardiovascular Disease Gerdisch et al
A
C
Dsurgical paradigm. Presented at the 13 International Society for Minimally Inva-
sive Cardiothoracic Surgery Annual Scientific Meeting, 2013.
25. Mumtaz S, Pretorius V, Madani M, Jamieson SW. CorMatrix fashioned tricuspid
valve as alternative to valve resection for acute infective endocarditis. Presented
at the 93rd Annual Meeting of the American Association for Thoracic Sur-
gery, 2013.
26. Spinner EM, Lerakis S, Higginson J, Pernetz M, Howell S, Veledar E, et al. Cor-
relates of tricuspid regurgitation as determined by 3D echocardiography: pulmo-
nary arterial pressure, ventricle geometry, annular dilatation, and papillary
muscle displacement. Circ Cardiovasc Imaging. 2012;5:43-50.
27. Spinner EM, Sundareswaran K, Dasi LP, Thourani VH, Oshinski J,
Yoganathan AP. Altered right ventricular papillary muscle position and orienta-
tion in patients with a dilated left ventricle. J Thorac Cardiovasc Surg. 2011;141:
744-9.Discussion
Dr Damien J. LaPar (Charlottesville, Va). Dr Gerdisch, I
would like to thank you very much for sending us the report ahead
of time and presenting a very provocative and novel concept for the
treatment of tricuspid valve endocarditis, which we all know is a
significant problem.
The authors of this report present 19 patients who underwent a
novel tricuspid valve replacement using a cylinder technique using
CorMatrix. Importantly, only 8 patients had follow-up data avail-
able at 6 months, and only 3 patients had follow-up for 1 year.
There were 3 patients who experienced failure of this de novo
valve owing to sutures pulling through the papillary muscles. We
have a few questions for you.
First, howwere your patients selected? It is not uncommon to be
able to prepare the tricuspid valve in the setting of endocarditis.
Can you tell us what the total denominator of all the patients
who underwent tricuspid valve surgery at your institutions,
including those repaired?
When did you elect to use this technique and when did you
repair, and when did you decide to perform a conventional
tricuspid valve replacement?
Dr Gerdisch. Thank you. Those are all excellent questions.
Unfortunately, I do not have information for all the institutions
with respect to how many tricuspid replacements and repairs were
performed during the same period. All the valves were deemed
irreparable by other methods. I agree that under certain circum-
stances, a tricuspid valve can well be repaired. These were all
deemed not repairable, completely destroyed valves.3048 The Journal of Thoracic and Cardiovascular SurIn regard to whether other patients received prostheses, I
cannot speak to that either. Typically, the factors that influenced
the surgeons were active infection, and, in fact, the high recidivism
with patients who were intravenous drug abusers.
Dr LaPar. Great. Thank you. My next question is more tech-
nical. The failure rate in this study was largely due to papillary
muscle rupture or sutures pulling through the annulus. In our expe-
rience at the University of Virginia, we had 1 failure due to the Pro-
lene sutures breaking at the level of the annulus on postoperative
day 1, which required a reoperation.
Why do you think this might have occurred, and are you doing
anything, particularly now, because youmentioned in your conclu-
sions that you are refining the technique, to secure the valve after
your experience here?
Dr Gerdisch. So that suture disruption was at the annulus, is
that what you said?
Dr LaPar. Yes.
DrGerdisch. That is even more unusual. We have not seen that.
I have not been aware of that actually and thank you for telling us
about it.
This, as you know, has been an attempt to accumulate the na-
tional experience. Also, you mentioned earlier that we have
limited follow-up, and it is true. One of the reasons that we decided
to press ahead with a publication was that we realized that people
were adopting, and we wanted to have a consensus idea from
everyone how they thought the application was going, what they
thought we should change about it, and also just to keep track.
As you mentioned, typically, papillary muscle disruption
seemed to be the mechanism of failure, and we, at our most recent
conversations about this, thought that perhaps there could be a
couple of mechanisms obviously. One would be that simply too
much tension is there. That limb that detaches might be too short;
that perhaps it is better to have a little bit too long than too short
when you build the cylinder. Also, it tends to be at the septal papil-
lary muscle, which frequently is not well defined and often one is
attaching to the endocardial surface of the heart, and it is more
difficult to define how deep to go and how nice a purchase you
can achieve there.
We need to continue to have those conversations. I think that
making the tube just a little bit more generous in length than short,
and also at the annulus, that is the first time we have seen that, but
trying to create an annulus of normal dimensions for the patient.
Dr LaPar. Thank you very much for this contribution.gery c December 2014
